View in EDS PDF Full Text

Comportamiento de la pubertad precoz central antes y durante la pandemia de SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Comportamiento de la pubertad precoz central antes y durante la pandemia de SARS-CoV-2.
Alternate Title: Trend of Central Precocious Puberty before and during SARS-CoV-2 pandemic.
Authors: Arancibia Cabalá, Mónica1, Pino Astorga, Sebastián2, Rivera Rivera, Alonso2, León Álvarez, Alba Luz3, Dubó Araya, Sebastián4, Campos Cerda, Laura1, Soto Barros, Julio1,5 soto.jb@gmail.com
Source: Andes Pediatrica. mar/abr2026, Vol. 97 Issue 2, p231-238. 8p.
Subjects: PRECOCIOUS puberty, COVID-19 pandemic, LUTEINIZING hormone, ENDOCRINE diseases, PUBERTY, SKELETAL maturity, BODY mass index
Abstract (English): During the SARS-CoV-2 pandemic, there was an increase in the diagnosis of endocrine disorders, notably the onset of central precocious puberty (CPP). Objective: To describe and compare the frequency of precocious puberty onset in two periods, before and during the SARS-CoV-2 pandemic. Patients and Method: Medical records with a confirmed diagnosis of CPP were reviewed from patients treated at Hospital Las Higueras, in Talcahuano, during two periods: 2019-2020 (Group 1, before the pandemic) and 2021-2022 (Group 2, during the pandemic). The variables studied were age at diagnosis, sex, age at onset of puberty, Body Mass Index (BMI) Z-score, Tanner stage, bone age, Luteinizing Hormone (LH), uterine size, and ovarian volumes at diagnosis. Results: There were 98 cases of precocious puberty in Group 1 (96.9% females) and 162 cases in Group 2 (95% females), showing a significant increase in CPP cases during the pandemic period (p < 0.001). Females presented with a higher BMI Z score and more advanced Tanner stage and bone age at diagnosis during the pandemic (p = 0.049, 0.07, and 0.06, respectively). Males were younger at diagnosis of precocious puberty in Group 2 (p = 0.019). Conclusions: Our data show a higher frequency of CPP onset in females and an earlier age at presentation in males during the pandemic period. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Durante la pandemia por SARS CoV-2 se observó un aumento en el diagnóstico de enfermedades endocrinológicas, destacando el debut de pubertad precoz central (PPC). Objetivo: Describir y comparar la frecuencia de debut de pubertad precoz en dos períodos, previo y durante la pandemia por SARS CoV-2. Pacientes y Método: Se revisaron las fichas clínicas con diagnóstico confirmado de PPC de pacientes atendidos en el Hospital Las Higueras, Talcahuano, en 2 períodos: 2019-2020 (Grupo 1, previo a la pandemia) y 2021-2022 (Grupo 2, durante la pandemia). Las variables estudiadas fueron: edad al diagnóstico, sexo, edad de inicio del desarrollo puberal, Z score de índice de masa corporal (IMC), estadio de Tanner, edad ósea, hormona luteinizante (LH), tamaño uterino y volúmenes ováricos al diagnóstico. Resultados: Se presentaron 98 casos de pubertad precoz en el Grupo 1 (96,9% niñas) y 162 casos en el Grupo 2 (95,0% niñas), evidenciándose en las niñas un aumento significativo de los casos de PPC durante el periodo de pandemia (p < 0,001). Las niñas presentaron un mayor z score de IMC, un estadio de tanner y una edad ósea más avanzados al diagnóstico durante la pandemia (p = 0,049, 0,007 y 0,06, respectivamente). En varones, la edad al diagnóstico de pubertad precoz fue menor durante la pandemia (p = 0,019). Conclusiones: Nuestros datos muestran una mayor frecuencia de debut de PPC en las niñas y una menor edad de presentación de ésta en los niños durante el periodo de pandemia. [ABSTRACT FROM AUTHOR]
Copyright of Andes Pediatrica is the property of Revista Chilena de Pediatria and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:During the SARS-CoV-2 pandemic, there was an increase in the diagnosis of endocrine disorders, notably the onset of central precocious puberty (CPP). Objective: To describe and compare the frequency of precocious puberty onset in two periods, before and during the SARS-CoV-2 pandemic. Patients and Method: Medical records with a confirmed diagnosis of CPP were reviewed from patients treated at Hospital Las Higueras, in Talcahuano, during two periods: 2019-2020 (Group 1, before the pandemic) and 2021-2022 (Group 2, during the pandemic). The variables studied were age at diagnosis, sex, age at onset of puberty, Body Mass Index (BMI) Z-score, Tanner stage, bone age, Luteinizing Hormone (LH), uterine size, and ovarian volumes at diagnosis. Results: There were 98 cases of precocious puberty in Group 1 (96.9% females) and 162 cases in Group 2 (95% females), showing a significant increase in CPP cases during the pandemic period (p < 0.001). Females presented with a higher BMI Z score and more advanced Tanner stage and bone age at diagnosis during the pandemic (p = 0.049, 0.07, and 0.06, respectively). Males were younger at diagnosis of precocious puberty in Group 2 (p = 0.019). Conclusions: Our data show a higher frequency of CPP onset in females and an earlier age at presentation in males during the pandemic period. [ABSTRACT FROM AUTHOR]
ISSN:24526045
DOI:10.32641/andespediatr.v97i2.5669